Anterogen.Co.Ltd Capital Reinvestment Ratio

Latest as of September 2025: 0.10x

Anterogen.Co.Ltd capital reinvestment ratio. Anterogen.Co.Ltd (065660) has a Capital Reinvestment Ratio of 0.10x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩281.98 Million) in capital expenditures (₩27.45 Million). Check total reinvestment intensity of Anterogen.Co.Ltd to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.10x

Capex / Operating Cash Flow

Operating Cash Flow

₩281.98 Million

KRW

Capital Expenditures

₩27.45 Million

KRW

Data as of

Sep 2025

Most recent filing

Capital Reinvestment Ratio of Anterogen.Co.Ltd (2015–2017)

Capital reinvestment ratio of Anterogen.Co.Ltd from 2015 to 2017. This chart tracks Anterogen.Co.Ltd's Capital Reinvestment Ratio across 2 annual periods. Also explore 065660 net asset momentum to track the company's year-over-year net asset growth rate.

Anterogen.Co.Ltd Capital Reinvestment Ratio by Year (2015–2017)

Anterogen.Co.Ltd capital reinvestment ratio by year from 2015 to 2017. For the full cash flow conversion analysis, see cash flow conversion of Anterogen.Co.Ltd.

Year	Reinvestment Ratio	Operating CF (KRW)	Capital Expenditures	YoY Change
2017	1.68x	₩379.21 Million	₩637.46 Million	▲ +115.4%
2015	0.78x	₩844.49 Million	₩659.00 Million	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow